Chronic leukemia

Results: 639



#Item
481Laboratory techniques / Molecular biology / Polymerase chain reaction / Xenotropic murine leukemia virus-related virus / Neurological disorders / Syndromes / Chronic fatigue syndrome / Judy Mikovits / Prostate cancer / Biology / Health / Science

Created on[removed]:41:00 PM Table. Prevalence Studies on XMRV and MLV-related Virus Infection in Human Diseases and General Populations * Study

Add to Reading List

Source URL: www.fda.gov

Language: English
482Medicine / Pharmacology / Pyrimidines / Drug safety / Orphan drugs / Chronic myelogenous leukemia / Food and Drug Administration / Ponatinib / Dasatinib / Piperazines / Chemistry / Organic chemistry

FDA Drug Safety Communication: FDA requires multiple new safety measures for leukemia drug Iclusig; company expected to resume marketing This information is in follow-up to the FDA Drug Safety Communication: FDA asks man

Add to Reading List

Source URL: www.fda.gov

Language: English
483Laboratory techniques / Molecular biology / Polymerase chain reaction / Leukemia / Minimal residual disease / Alemtuzumab / B-cell chronic lymphocytic leukemia / Biology / Chemistry / Science

4° Nordic CLL Meeting Copenhagen, September 11, 2008

Add to Reading List

Source URL: www.fda.gov

Language: English
484Doctoral degrees / Doctor of Medicine / Higher education / Minimal residual disease / Education / Academia / Knowledge

Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL) Workshop R. Angelo de Claro, M.D., William Wierda, M.D., Ph.D., and Gregory Reaman, M.D., Co-Chairs

Add to Reading List

Source URL: www.fda.gov

Language: English
485Clinical trials / Epidemiology / Medical research / Medical terms / FDA Fast Track Development Program / Surrogate endpoint / Minimal residual disease / B-cell chronic lymphocytic leukemia / Center for Devices and Radiological Health / Medicine / Health / Food and Drug Administration

Transcript: Public Workshop on Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL)

Add to Reading List

Source URL: www.fda.gov

Language: English
486

Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL) Workshop DISCUSSION POINTS

Add to Reading List

Source URL: www.fda.gov

    487Occupational safety and health / Pathology / Leukemia / B-cell chronic lymphocytic leukemia / Myeloid leukemia / Medicine / Health / Cancer

    Compensation Rates by[removed]xlsx

    Add to Reading List

    Source URL: www.cdc.gov

    Language: English - Date: 2014-03-04 09:23:55
    488Myeloid leukemia / Acute leukemia / Lymphoma / B-cell chronic lymphocytic leukemia / Hematological malignancy / Leukemia / Acute myeloid leukemia / Hairy cell leukemia / Lymphoid leukemia / Oncology / Medicine / Lymphocytic leukemia

    Consultant’s report Dose reconstruction project Dr Mark Crowther, MD, MSc, FRCPC General comments: In general, anything currently classified as a Leukemia (including those discussed below that I feel should be reclassi

    Add to Reading List

    Source URL: www.cdc.gov

    Language: English - Date: 2005-12-21 13:43:04
    489Occupational safety and health / National Institute for Occupational Safety and Health / B-cell chronic lymphocytic leukemia / Lymphocytic leukemia / Hematologic neoplasms / Leukemia / Radiation dose reconstruction / Energy Employees Occupational Illness Compensation Program / Hematological malignancy / Medicine / Health / Radiobiology

    [removed]Federal Register / Vol. 76, No[removed]Monday, March 21, [removed]Proposed Rules section of this document. Docket: For access to the docket to

    Add to Reading List

    Source URL: www.cdc.gov

    Language: English - Date: 2011-03-22 10:56:37
    490Lymphocytic leukemia / Physical exercise / Social psychology / Psychology / Physical Activity Guidelines for Americans / Power / Science / Health / Behavioural sciences / Behavior / B-cell chronic lymphocytic leukemia

    September 13, 2012 The Bulletin Page 11

    Add to Reading List

    Source URL: www.umanitoba.ca

    Language: English - Date: 2014-06-12 12:18:02
    UPDATE